Načítá se...
ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions
BACKGROUND: Expansion of type 2 innate lymphoid cells (ILC2s) in hypercholesterolaemic mice protects against atherosclerosis while different ILC2 subsets have been described (natural, inflammatory) based on their suppression of tumorigenicity 2 (ST2) and killer-cell lectin like receptor G1 (KLRG1) e...
Uloženo v:
| Vydáno v: | BMC Immunol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6905041/ https://ncbi.nlm.nih.gov/pubmed/31823769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12865-019-0330-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|